Alterity Therapeutics (ATHE) Stock Price, Quote, News & History

Q: What sector and industry does Alterity Therapeutics (ATHE) operate in?

Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Alterity Therapeutics (ATHE) Stock Price, Quote, News & History

ATHENASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$3.17

-0.09-2.76%

At close: Jan 30, 4:00 PM EST

$3.44

0.278.52%

After Hours: Jan 30, 9:02 AM EST

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$3.16

$3.17

Volume / Avg.

14.52K / 16.03K

Day Range

$3.07 - $3.25

52 Wk Range

2.52 - 7.00

Market Cap

$62.35M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent Alterity Therapeutics Ltd News

Why Levi Strauss Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

Levi Strauss & Co. (NYSE: LEVI) stock rose as Q2 results beat expectations and full-year guidance was raised. Other gainers and losers noted.

Avi Kapoor

Nasdaq Moves Lower; Meta Platforms Posts Strong Sales

Avi Kapoor

What's Going On With Alterity Therapeutics Shares Thursday?

Alterity Therapeutics shares are moving higher on Thursday after the company reported positive topline results from its Phase 2 clinical trial of ATH434 in early-stage multiple system atrophy.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-7.50M

Financing Cash Flow (TTM)

58.98M

Free Cash Flow (TTM)

-13.49M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

37.99M

Analyst Trends and Forecast

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.7

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$25.10M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

1.99

Earnings Yield % (TTM)

Earnings Yield % (FWD)

-656.86%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$1.64

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$160.10K

Total Cash

Debt to Equity

0.00

Issuance of Debt (TTM)

-$160.10K

Repayment of Debt (TTM)

-$160.10K

Key Statistics

Open

$3.16

$3.17

Volume / Avg.

14.52K / 16.03K

Day Range

$3.07 - $3.25

52 Wk Range

2.52 - 7.00

Market Cap

$62.35M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's diseas...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Alterity Therapeutics (ATHE) stock?

You can purchase shares of Alterity Therapeutics (NASDAQ:ATHE) through any online brokerage.

View our list of the best stock brokerages

Who are Alterity Therapeutics (ATHE) competitors?

Other companies in Alterity Therapeutics’s space includes: InflaRx NV (NASDAQ:IFRX), Gain Therapeutics Inc (NASDAQ:GANX), Coeptis Therapeutics Holdings Inc (NASDAQ:COEP), Aligos Therapeutics Inc (NASDAQ:ALGS) and Entera Bio Ltd (NASDAQ:ENTX).

What is the forecast, or price target, for Alterity Therapeutics (ATHE) stock?

Alterity Therapeutics has a consensus price target of $8.67.

What is the current price for Alterity Therapeutics (ATHE)?

The stock price for Alterity Therapeutics (NASDAQ: ATHE) is $3.44 last updated January 30, 2026 at 9:02 AM EST.

Does Alterity Therapeutics (ATHE) pay a dividend?

There are no upcoming dividends for Alterity Therapeutics.

When is Alterity Therapeutics (NASDAQ:ATHE) reporting earnings?

Alterity Therapeutics does not have any upcoming earnings scheduled.

Is Alterity Therapeutics (ATHE) going to split?

There is no upcoming split for Alterity Therapeutics.

What sector and industry does Alterity Therapeutics (ATHE) operate in?

Alterity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Gain Therapeutics Inc

NASDAQ:GANX

$1.82

1.17%

Coeptis Therapeutics Holdings Inc

NASDAQ:COEP

$14.13

1.95%

Aligos Therapeutics Inc

Tevogen Bio Holdings Inc

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$3.16

$3.17

Volume / Avg.

14.52K / 16.03K

Day Range

$3.07 - $3.25

52 Wk Range

2.52 - 7.00

Market Cap

$62.35M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent Alterity Therapeutics Ltd News

Why Levi Strauss Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

Levi Strauss & Co. (NYSE: LEVI) stock rose as Q2 results beat expectations and full-year guidance was raised. Other gainers and losers noted.

Avi Kapoor

Nasdaq Moves Lower; Meta Platforms Posts Strong Sales

Avi Kapoor

What's Going On With Alterity Therapeutics Shares Thursday?

Alterity Therapeutics shares are moving higher on Thursday after the company reported positive topline results from its Phase 2 clinical trial of ATH434 in early-stage multiple system atrophy.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-7.50M

Financing Cash Flow (TTM)

58.98M

Free Cash Flow (TTM)

-13.49M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

37.99M

Analyst Trends and Forecast

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.7

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$25.10M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

1.99

Earnings Yield % (TTM)

Earnings Yield % (FWD)

-656.86%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$1.64

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$160.10K

Total Cash

Debt to Equity

0.00

Issuance of Debt (TTM)

-$160.10K

Repayment of Debt (TTM)

-$160.10K

Key Statistics

Open

$3.16

$3.17

Volume / Avg.

14.52K / 16.03K

Day Range

$3.07 - $3.25

52 Wk Range

2.52 - 7.00

Market Cap

$62.35M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry